Journal article
Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension
SL Burke, B Barzel, KL Jackson, C Gueguen, MJ Young, GA Head
Frontiers in Physiology | FRONTIERS MEDIA SA | Published : 2021
Abstract
The hypothalamic paraventricular nucleus (PVN) is an important site where an interaction between circulating angiotensin (Ang) and mineralocorticoid receptor (MR) activity may modify sympathetic nerve activity (SNA) to influence long-term elevation of blood pressure. We examined in conscious Ang II-treated rabbits, the effects on blood pressure and tonic and reflex renal SNA (RSNA) of microinjecting into the PVN either RU28318 to block MR, losartan to block Ang (AT1) receptors or muscimol to inhibit GABAA receptor agonist actions. Male rabbits received a moderate dose of Ang II (24 ng/kg/min subcutaneously) for 3 months (n = 13) or sham treatment (n = 13). At 3 months, blood pressure increas..
View full abstractGrants
Awarded by Baker Heart and Diabetes Institute
Funding Acknowledgements
This project was funded by the Australian National Health and Medical Research Council (NHMRC) project grant number 1043718. GH was supported by NHMRC Principal Research Fellowship (APP367631). MY was supported by the Alice Baker and Eleanor Shaw Gender Equity Fellowship from the Baker Heart and Diabetes Institute, Perpetual Trustees and Diabetes Australia. This study was supported in part by the Victorian Government's Operational Infrastructure Support Program.